“Before we can discover new treatments for brain-related diseases such as Alzheimer’s and Parkinson’s, we need to understand the human genetic blueprint – DNA – that determines how the brain works in healthy individuals,” he said. “Then we will be better equipped to develop new medicines and therapies for individuals with brain disorders.”Matt Huentelman, PhD, Professor, Neurogenomics Division, Translational Genomics Research Institute (TGen)
In this profile in the Phoenix Business Journal, Dr. Matt Huentelman explains how crowdsourcing and his goal of reaching 1 million people may hold the keys to understanding the genetic underpinnings of Alzheimer’s disease and other brain-related disorders.
Visit the Phoenix Business Journal
And meet the TGen Alzheimer’s expert who wants to test 1 million people.
FIND OUT MORE ABOUT YOUR BRAIN.
Discover how it compares with others like you in 10 short minutes by playing the free online MindCrowd memory game.
And help scientists find new ways to protect our brains from memory loss as we age.
Stay Tuned for News about Brain Aging and How to Avoid Cognitive Decline.